
handle: 10616/39471
This thesis describes DNA-based vaccination and the importance of bacterial DNA in different immunological perspectives. Intranasal (i.n.) DNA vaccination utilizing a plasmid encoding the chlamydial heat shock protein 60 (p-hsp-60) generated lower bacterial burden and reduced pathology in the lungs of mice after subsequent infection with C. pneumoniae. This DNA vaccine- induced protection was dependent on T cells and induction of IFN-gamma. Co-administration of a plasmid encoding IL-12 ftirther enhanced the protective effect of the DNA vaccine. Interestingly, in the absence of CD8 T cells, CD4 T cells induced by the p-hsp-60 DNA vaccine were involved in deteriorating the outcome of infection. This detrimental response was linked to a shift towards a Th2 cytokine profile in the lungs. In. DNA vaccination using the chlamydial outer membrane protein 2 (OMP- 2) combined with a CTLA-4 expression system also generated reduction of bacterial load in mouse lung after C. pneumoniae infection compared to controls. In contrast, subcutaneous (s.c.) OMP-2 protein-based immunization in Freund's complete adjuvant (FCA) generated increased lung bacterial load, with increased disease severity. This pathological outcome of disease was dependent on T cells and associated with a Th2 immune response. When oligodeoxynucleotides containing CpG motifs mixed with Freund's incomplete adjuvant (FIA- CpG ODN) were used as adjuvant this detrimental response was shifted towards partial protection against infection. This partial protection was linked to a Th1 type of immune response. In an approach to identify protein(s) that are included in CpG DNA stimulation, an isolation procedure was developed for a crude protein extract prepared from peripheral blood mononuclear cells (PBMC). The binding between the protein(s) and CpG ODN in the extract was followed by electromobility shift assay (EMSA) analysis. Using a Series of different chromatographic purification steps and protein sequence analysis, heat shock protein 90 (hsp90) was identified as ...
DNA vaccine, 570, CpG DNA, Thesis, 610, antimicrobial peptides C. pneumoniae, Shigella spp
DNA vaccine, 570, CpG DNA, Thesis, 610, antimicrobial peptides C. pneumoniae, Shigella spp
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
